Mixed Data For Bluebird's LentiGlobin, But Conditional Approval On The Cards

 
• By Lucie Ellis-Taitt
Blood sample
Bluebird looks towards 2017 EU conditional approval for LentiGlobin as beta-thalassemia gene therapy • Source: Shutterstock

More from Blood and Clotting

More from Therapeutic Category